NRC — Human Health Therapeutics Research Centre
Canada
Collaborate on human health therapeutics R&D
grant_single_labels|summary
grant_single|eligibleFinancing
- grant_single|noCondition
grant_single|deadlines
- grant_single|openingDateNovember 14, 2019
grant_single|financingType
Expert Advice
Researchers And Facilities
grant_single|eligibleIndustries
- Manufacturing
- Professional, scientific and technical services
- Health care and social assistance
grant_single|grantors
- National Research Council Canada (NRC)
- Government of Canada
grant_single|status
grant_card_status|open
grant_single_labels|preview
Access technical and advisory services, research facilities and licensing opportunities for human health therapeutics research.
grant_single_labels|projects
grant_single|admissibleProjectsExample
$750,000
Creation of an innovative biologic to tackle autoimmune diseases
$900,000
Research and development of novel biologics for cancer treatment
$600,000
Development of a new gene therapy targeting rare genetic disorders
$750,000
Production of a novel biologic for infectious disease treatment
$850,000
Development of cell therapy for treating cardiovascular diseases
$400,000
Optimization of biomanufacturing processes for complex biologics
grant_single_labels|admissibility
grant_eligibility_criteria|eligible_expenses
This grant supports initiatives aimed at advancing biologics development and production, with a focus on tackling complex health challenges. Eligible projects include collaboration across research and development, innovative production processes, and therapy advancements.
- Design and development of innovative biologics for emerging infections, cancer, and neurological diseases.
- Biomanufacturing improvements to optimize production processes for complex biologics.
- Advancement of cell and gene therapies through collaborative projects.
- Preclinical research and development utilizing in vivo and in vitro testing.
- Scaling up bioprocesses for clinical trial material production compliant with GMP.
- Collaborative research initiatives to combat antimicrobial resistance.
- Development of CAR T-cell cancer therapies made in Canada.
grant_single_labels|criteria
There are evaluation and selection criteria for this grant. The evaluation and selection criteria are as follows:
- Relevance of the project to advancing novel biologics
- Scientific merit and innovation of the proposed research
- Feasibility and technical soundness of the project
- Alignment with the organization's strategic priorities
- Potential impact on public health and patient outcomes
grant_single_labels|register
Here are the steps to submit an application for this grant:
- Step 1: Preliminary Research and Collaboration
- Review the research publications and programs to identify areas of expertise that align with your project.
- Contact Sue Twine or Paul Payette to discuss potential collaboration opportunities and gain insights about the grant application process.
- Step 2: Draft Proposal
- Prepare a proposal that outlines the project's objectives, research methodologies, and anticipated outcomes.
- Include details about how your project will contribute to the advancement of biologics, biomanufacturing, or cell and gene therapies.
- Step 3: Compile Supporting Documents
- Gather all necessary documents including project timelines, budgets, letters of support from collaborators, and CVs of key team members.
- Ensure all documents adhere to the grant's guidelines and requirements.
- Step 4: Submit Application
- Email the completed application and supporting documents to the appropriate contact as specified, such as Susan.Twine@nrc-cnrc.gc.ca or Paul.Payette@nrc-cnrc.gc.ca.
- Make sure to submit the application before any specified deadline to ensure consideration.
- Step 5: Confirmation and Follow-Up
- Await confirmation of receipt from the grant body.
- Follow up if needed, using the contact information provided, to ensure the application is being processed.
grant_single_labels|otherInfo
Here are additional relevant details for this grant:
- Collaboration with industry, hospitals, health networks, academia, and government is encouraged to advance novel biologics.
- Access to multidisciplinary expertise and leading-edge facilities is available for the biologics development process, from discovery to clinical material production.
- Support for generating high-potential candidates using advanced proprietary technologies is provided.
- Preclinical R&D capabilities include small-scale manufacturing and both in vivo and in vitro testing expertise.
- Bioprocess improvements can be conducted in specialized R&D labs focusing on analytics, modelling, and intensification.
- Production facilities are available for optimizing bioprocesses and producing clinical trial materials compliant with good manufacturing practices (GMP).
- A directory of science professionals and researcher profiles is accessible, offering insights into their projects and expertise.
Apply to this program
Grant Summary
This grant focuses on designing, developing, and producing innovative biologics in Canada to address complex health challenges such as emerging infections, cancer, and neurological diseases. The National Research Council of Canada collaborates with various entities to advance novel biologics through multidisciplinary expertise and cutting-edge facilities.
Exploring Innovative Biologics Development in Canada
The National Research Council of Canada is at the forefront of biologics development, specializing in the creation of vaccines and therapeutics derived from living organisms. With a focus on addressing pressing health issues like cancer and infections, the NRC leverages its research programs and unique facilities to design, develop, and test novel biologics.
Biologics, such as cell and gene therapies, are key components in treating and preventing diseases, and the NRC's expertise spans the entire biologics development process. From designing high-potential candidates to optimizing bioprocesses in compliance with good manufacturing practices, the NRC collaborates with industry, academia, and government to drive innovation in biologics production.
The NRC's multidisciplinary approach involves small-scale manufacturing capabilities for evaluating biologic candidates, in vivo and in vitro testing expertise for preclinical R&D, and advanced bioprocess R&D capabilities for process improvement. With a focus on personalized and off-the-shelf biologics, the NRC engages in cutting-edge research to enhance the production process for complex biologics.
Through collaboration with industry partners, health networks, and academic institutions, the NRC aims to accelerate the development and production of Canadian-made biopharmaceuticals. By bridging the gap between research and commercialization, the NRC's efforts contribute to the advancement of clinical trial material for innovative biologics in Canada.
